by Steven Grossman | Aug 28, 2025 | Short Takes and Updates
For much of the past 20 years, my primary professional responsibility has been to impress upon lawmakers, the media, and stakeholders that FDA’s value far exceeds its budget. Sometimes, I would emphasize the economics — FDA oversees goods and services that total...
by Steven Grossman | Aug 20, 2025 | Short Takes and Updates
(An earlier version of this column appeared in Food Safety News at https://bit.ly/417cLOJ) —————Preamble: The Make America Healthy Again (MAHA) movement has sparked an overdue examination of how to improve the health of Americans,...
by Steven Grossman | Aug 12, 2025 | Short Takes and Updates
FDA Matters doesn’t cover the news….we provide analysis of what’s behind the newsThe goal of FDA Matters is to analyze FDA policy and regulatory issues and advocate for a more effective, more efficient, and fairer FDA. In support of the agency, I...
by Steven Grossman | Aug 8, 2025 | Short Takes and Updates
FDA Matters doesn’t cover the news….we provide analysis of what’s behind the newsThis week: August in DC—No Longer SlowThe Difficult Path to An FDA that Is “Just Right,” Neither Too Hard Nor Too Soft Former FDA Commissioner David Kessler...
by Steven Grossman | Jul 31, 2025 | Short Takes and Updates
Every day, we are failing patients with chronic progressive neurological, neuromuscular, and genetic diseases. The brouhaha about Sarepta and Elevidys[1][2] is just a reminder that we are not systematically addressing the common plight of these patients: 1/ their...
by Steven Grossman | Jul 25, 2025 | Short Takes and Updates
FDA Matters doesn’t cover the news….we provide analysis of what’s behind the newsThis week: Familiarity Breeds Respect Imminent Danger Regarding Food Priorities New CDER Leadership Re-Exploring Reconciliation Cuts’ Impact on FDA Consumer Protection...
